Deborah Crouch

Array ( [id] => 4257215 [patent_doc_number] => 06204052 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Adenoviral vectors with reduced TNF response and partial E3 region deletion' [patent_app_type] => 1 [patent_app_number] => 8/515495 [patent_app_country] => US [patent_app_date] => 1995-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 28 [patent_no_of_words] => 11283 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204052.pdf [firstpage_image] =>[orig_patent_app_number] => 515495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3818694 [patent_doc_number] => 05789653 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Secretory gene trap' [patent_app_type] => 1 [patent_app_number] => 8/497076 [patent_app_country] => US [patent_app_date] => 1995-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 7109 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789653.pdf [firstpage_image] =>[orig_patent_app_number] => 497076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3734260 [patent_doc_number] => 05698443 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Tissue specific viral vectors' [patent_app_type] => 1 [patent_app_number] => 8/495034 [patent_app_country] => US [patent_app_date] => 1995-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5006 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698443.pdf [firstpage_image] =>[orig_patent_app_number] => 495034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3731024 [patent_doc_number] => 05693622 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Expression of exogenous polynucleotide sequences cardiac muscle of a mammal' [patent_app_type] => 1 [patent_app_number] => 8/480039 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 29081 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693622.pdf [firstpage_image] =>[orig_patent_app_number] => 480039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726270 [patent_doc_number] => 05702932 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-30 [patent_title] => 'Microinjection methods to transform arthropods with exogenous DNA' [patent_app_type] => 1 [patent_app_number] => 8/479485 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 9233 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/702/05702932.pdf [firstpage_image] =>[orig_patent_app_number] => 479485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3812683 [patent_doc_number] => 05811633 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Transgenic mouse expressing APP.sub.770' [patent_app_type] => 1 [patent_app_number] => 8/482027 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 14 [patent_no_of_words] => 10002 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811633.pdf [firstpage_image] =>[orig_patent_app_number] => 482027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4047053 [patent_doc_number] => 05932241 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Cationic lipid DNA complexes for gene targeting' [patent_app_type] => 1 [patent_app_number] => 8/480923 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 22 [patent_no_of_words] => 8568 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932241.pdf [firstpage_image] =>[orig_patent_app_number] => 480923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1248406 [patent_doc_number] => 06673776 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => 'Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human' [patent_app_type] => B1 [patent_app_number] => 08/481932 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 23447 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673776.pdf [firstpage_image] =>[orig_patent_app_number] => 08481932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 931173 [patent_doc_number] => 06979677 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-12-27 [patent_title] => 'Inhibition of vascular smooth muscle cell proliferation' [patent_app_type] => utility [patent_app_number] => 08/480038 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4266 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/979/06979677.pdf [firstpage_image] =>[orig_patent_app_number] => 08480038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1210535 [patent_doc_number] => 06713662 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Production of collagen in the milk of transgenic mammals' [patent_app_type] => B1 [patent_app_number] => 08/482173 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 11 [patent_no_of_words] => 13287 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713662.pdf [firstpage_image] =>[orig_patent_app_number] => 08482173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4299265 [patent_doc_number] => 06184435 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Transgenic mouse expressing APP770-V717F' [patent_app_type] => 1 [patent_app_number] => 8/475176 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 3366 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184435.pdf [firstpage_image] =>[orig_patent_app_number] => 475176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3989280 [patent_doc_number] => 05891665 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Untranslated leader sequences from RNA viruses as enhancers of translation' [patent_app_type] => 1 [patent_app_number] => 8/474010 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 37 [patent_no_of_words] => 7484 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891665.pdf [firstpage_image] =>[orig_patent_app_number] => 474010 [rel_patent_id] =>[rel_patent_doc_number] =>)